Advertisement

Topics

CRISPR Therapeutics Hires Tony Ho From AstraZeneca to Lead R&D

11:49 EDT 4 Aug 2017 | Xconomy

CRISPR Therapeutics (NASDAQ: CRSP) has hired Tony Ho to serve as the company’s executive vice president and head of research and development. Switzerland-based CRISPR Therapeutics, which maintains its R&D operations in Cambridge, MA, is developing therapies based on the CRISPR gene-editing technology. Ho comes to the company from AstraZeneca (NYSE: AZN), where he was senior […]

Original Article: CRISPR Therapeutics Hires Tony Ho From AstraZeneca to Lead R&D

NEXT ARTICLE

More From BioPortfolio on "CRISPR Therapeutics Hires Tony Ho From AstraZeneca to Lead R&D"

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...